(C) 2024 Electronic News Publishing, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.17 USD | -0.43% | -0.05% | -0.54% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.54% | 7.72B | |
+9.35% | 114B | |
+11.44% | 104B | |
-13.57% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.79% | 17.89B | |
+7.67% | 14.28B | |
+34.52% | 12.55B |
- Stock Market
- Equities
- CERE Stock
- News Cerevel Therapeutics Holdings, Inc.
- Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease